Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
Clinical trial NCT01273376 · COMPLETED
Trial details
- NCT number
- NCT01273376
- Sponsor
- Rexahn Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2011-09-01
- Enrollment
- 314
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.